Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Grosseto – page 2

27 clinical trials in Grosseto, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Grosseto at a glance
27
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

27 trials in Grosseto

Open in trial search

Colon cancer stage III+1

Not yet recruiting

Study on Post-Surgery Treatment for Colon Cancer Patients Using Trifluridine, Irinotecan, and Drug Combination

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fondazione GONO G.I.

Cardiac failure

Not recruiting

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Neoplasm

Not recruiting

Study on the Safety and Tolerability of TransCon IL-2 β/γ, Pembrolizumab, and Chemotherapy in Adults with Advanced or Metastatic Solid Tumors

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:ACP-017
  • Sponsor:Ascendis Pharma Oncology Division A/S

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not recruiting

Study of pelacarsen and inclisiran in patients with atherosclerotic cardiovascular disease who have high levels of LDL cholesterol and lipoprotein(a)

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

HIV infection

Not recruiting

Study on Early Switching to Dolutegravir and Lamivudine for Adults with HIV-1 on Three-Drug Regimen with Virological Suppression

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dolutegravir
  • Sponsor:Societa Italiana Di Malattie Infettive E Tropicali SIMIT

Cardiogenic shock

Not recruiting

Study Comparing Norepinephrine and Dobutamine for Patients with Cardiogenic Shock

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dobutamine
  • Sponsor:Azienda Unita' Sanitaria Locale Toscana Sud Est

Study on Avelumab for Patients with High-Risk Triple Negative Breast Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Universita Degli Studi Di Padova

Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:ABCSG GmbH

Study Comparing Panitumumab and Regorafenib Sequence for Patients with Metastatic Colorectal Cancer Resistant to Previous Treatments

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Panitumumab
  • Sponsor:Fondazione GONO G.I.

Breast neoplasm

Not recruiting

Study Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Eli Lilly & Co.

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Grosseto

What the registry says about research in the country

01 Cardiology Research

Studies focusing on cardiogenic shock treatment strategies and innovative approaches for managing acute myocardial infarction. Research includes evaluating medications like evolocumab and investigating treatments for cardiovascular disease prevention.

  • Cardiogenic Shock Management
  • Heart Attack Treatment
  • Cardiovascular Disease Prevention

Novel therapeutic approaches comparing different medication combinations to improve patient outcomes.

02 Oncology Studies

Comprehensive research into various cancer types, with particular focus on breast cancer and colorectal cancer treatments. Studies evaluate new drug combinations and maintenance therapies.

  • Advanced Breast Cancer Therapies
  • Colorectal Cancer Treatments
  • Ovarian Cancer Research

Investigating targeted therapies and immunotherapy approaches for better treatment outcomes.

03 Infectious Disease Research

Studies examining treatment optimization for HIV-1 infected individuals, focusing on evaluating two-drug versus three-drug regimens and their long-term effectiveness.

  • HIV Treatment Optimization
  • Antiviral Therapy Assessment
  • Drug Regimen Comparison

Research aims to improve treatment efficiency while maintaining viral suppression.

04 Neurological Studies

Investigation of innovative treatments for Parkinson's disease, including continuous subcutaneous medication delivery systems to improve motor function control.

  • Motor Function Management
  • Drug Delivery Systems
  • Symptom Control

Focus on improving quality of life for patients with movement disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.